California Health and Safety Code

§ 25201.17

HSC § 25201.17 Effective Jan 1, 2007Div. 20 · Ch. 6.5 · Art. 9

Statute text

(a)For purposes of this section, the following terms have the following meanings:

(1)“Pharmaceutical manufacturing or pharmaceutical process development activities” means activities conducted in North American Industry Classification System Code subgroups 325411 and 325412, to the extent they meet either of the following:

(A)Research, development, and production activities conducted in relation to an investigational new drug application or new drug application as set forth in Part 312 (commencing with Section 312.1) of, and Part 314 (commencing with Section 314.1) of, Subchapter D of Chapter 1 of Title 21 of the Code of Federal Regulations, that is filed with the United States Food and Drug Administration, or research and development activities conducted to support the future filing of an investigational new drug application or new drug application, or research, development, and production activities that are conducted in relation to a filing with a corresponding governmental authority in the European Union, Japan, or Canada that imposes similar requirements.

…

Legislative history

Added by Stats. 2006, Ch. 741, Sec. 1. Effective January 1, 2007.